Advertisement
Prior to joining Wyeth, Mr. Cost was Executive Vice President, CorporateAffairs at ARAMARK since 2003. During his 27-year career, he has served insenior executive roles for several leading companies. He formerly was SeniorVice President of Corporate Affairs for Pharmacia and, prior to that, VicePresident of Investor Relations and Corporate Intelligence for Bristol-MyersSquibb Company. He also served as Senior Vice President, Communications andStrategy for Centocor, Inc. Mr. Cost began his career with Kodak, holding anumber of management positions with the company, including Director ofStrategic Planning, Worldwide Operations and Vice President, InvestorRelations.
Advertisement
Mr. Cost earned his undergraduate degree from Jacksonville University inFlorida and holds an M.B.A. in Finance and Economics from the William E. SimonGraduate School of Business at the University of Rochester.
"I am pleased to have a leader of Tim's caliber joining the seniormanagement team," says Bernard Poussot, President and Chief Executive Officer,Wyeth. "His extensive and broad experience, especially in the biotechnologyand pharmaceutical sectors, will help us as we continue to deliver innovativenew products and navigate the changing business environment."
Ms. Rhudy joined Wyeth in 1993 as Assistant Vice President, ProfessionalRelations for Wyeth's pharmaceuticals division and held positions ofincreasing responsibility while building Wyeth's public affairs function. Shewas promoted to Vice President, Corporate Public Affairs, Wyeth in 1997 andSenior Vice President, Corporate Public Affairs, Wyeth in 2004. Beforejoining Wyeth, she was appointed by the President to the White House HealthCare Professionals Task Force on Health Care Reform in 1993.
"Marily has built an outstanding public affairs team that has forgedstrong external relationships to raise the level of awareness of Wyeth'scontributions to health care," says Mr. Poussot. "In addition, her team haspartnered across the Wyeth divisions to resolve complex business and productissues and to help the Company achieve its business goals. We thank Marilyfor her many contributions to our business."
Wyeth is one of the world's largest research-driven pharmaceutical andhealth care products companies. It is a leader in the discovery, development,manufacturing and marketing of pharmaceuticals, vaccines, biotechnologyproducts and non-prescription medicines that improve the quality of life forpeople worldwide. The Company's major divisions include WyethPharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
SOURCE Wyeth
